| Regulatory Story | ||||||||||||
| Go to market news section |
|
|||||||||||
|
||||||||||||
RNS Number : 2400Y
GlaxoSmithKline PLC
19 February 2013
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
On 18 February 2013, GlaxoSmithKline plc was advised by its US Retirement Savings Plan (The Plan) manager that a transaction for the acquisition of 50 ADS at a price of $45.50 per ADS in the Company had been processed on behalf of Mr W Louv, a Person Discharging Managerial Responsibility. This transaction was an administrative error and is to be reversed. Accordingly, Mr Louv's interest in the issued share capital of the Company has not changed.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
19 February 2013
This information is provided by RNS
The company news service from the London Stock Exchange
 |
 |
| London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply. |
| © London Stock Exchange plc. All rights reserved |